Financials data is unavailable for this security.
View more
Income statement information is not available for Biostem Technologies Inc .
Gross margin | 94.73% |
---|---|
Net profit margin | 5.98% |
Operating margin | 8.94% |
Return on assets | 16.78% |
---|---|
Return on equity | 122.31% |
Return on investment | 107.11% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Biostem Technologies Inc fell by 532.73k. Cash Flow from Financing totalled 3.18m or 19.04% of revenues. In addition the company used 3.50m for operations while cash used for investing totalled 210.33k.
Cash flow per share | 0.4497 |
---|---|
Price/Cash flow per share | 19.66 |
Book value per share | 1.11 |
---|---|
Tangible book value per share | 1.08 |
More ▼
Balance sheet in USDView more
Current ratio | 1.22 |
---|---|
Quick ratio | 1.20 |
Total debt/total equity | 0.2519 |
---|---|
Total debt/total capital | 0.2012 |
More ▼